Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Terbinafine can cause hair loss.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Cyclosporin doesn't stop hair loss.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Baricitinib is effective and safe for treating severe alopecia areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Baricitinib shows promise for treating alopecia areata with mild side effects.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.